Sanj Kumar joins Atelerix as Chief Business Officer
November 18th 2019 -- Cambridge and Newcastle, UK – Atelerix, pioneers in the storage and…
read moreDr. Andrew Muir is a Director of Midven, an FCA-authorised fund management company, and is the Investment Director for the UK Innovation & Science Seed Fund. He also manages the Stephenson Fund. Starting his career at Zeneca in advanced materials, he went on to roles in research and business development at the medical device company Biocompatibles and then Vice President of Technology for a US start-up in disinfection of medical equipment.
He started his career in venture capital with NESTA (the National Endowment for Science Technology and the Arts). He has a degree and a PhD in Chemistry from the University of Oxford.
Telephone 0121 710 1990
“Development and commercialisation of new technologies is key to the UK retaining its global competitiveness.”
November 18th 2019 -- Cambridge and Newcastle, UK – Atelerix, pioneers in the storage and…
read moreLondon, UK, 8th November 2019: UK Innovation & Science Seed Fund (UKI2S) is delighted to…
read more. Cambridge and Newcastle, UK, 21st August 2019: Atelerix, pioneers in the storage and…
read moreCell encapsulation for transport of cells and tissues at room temperature 9th May 2019 --…
read moreCreating smart textiles by adding conductivity to fabrics at any stage Pireta has developed a…
read moreInsight From Light Cobalt Light Systems develops innovative instruments and technologies for non-invasive, rapid analysis…
read moreSummary Oxsensis is pioneering a “new breed” of highly accurate, highly stable optical sensors. Using…
read moreAndrew Muir, PhD, is a director at Midven, and leads the UK Innovation & Science…
read moreCreating a new technology company is an exciting time. It is an opportunity to get…
read more